To elucidate how EBV infection impairs NK cell cytotoxic function in NPC and to explore the therapeutic potential of combining B7-H3 deletion on tumour cells with anti-PD-L1 treatment to restore NK cell-mediated antitumour activity. The gene discussed is CD274; the disease is Epstein-Barr virus infection.